These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18276790)

  • 1. The source of neointimal cells in vein grafts: does the origin matter?
    Rienstra H; Zeebregts CJ; Hillebrands JL
    Am J Pathol; 2008 Mar; 172(3):566-70. PubMed ID: 18276790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced neointima in vein grafts following a blockage of cell recruitment from the vein and the surrounding tissue.
    Fogelstrand P; Osterberg K; Mattsson E
    Cardiovasc Res; 2005 Aug; 67(2):326-32. PubMed ID: 15885671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-bone marrow origin of neointimal smooth muscle cells in experimental in-stent restenosis in rats.
    Groenewegen HC; Onuta G; Goris M; Zandvoort A; Zijlstra F; van Gilst WH; Rozing J; de Smet BJ; Roks AJ; Hillebrands JL
    J Vasc Res; 2008; 45(6):493-502. PubMed ID: 18434748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of early growth response gene-1 and its correlative genes in autogenous vein graft and significance thereof: an experiment with rats].
    Liu CW; Hu XH; Yang J; Zhang Q; Zhang XS; Duan ZQ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3414-8. PubMed ID: 16409863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.
    Zhang L; Hagen PO; Kisslo J; Peppel K; Freedman NJ
    J Vasc Surg; 2002 Oct; 36(4):824-32. PubMed ID: 12368745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
    Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
    Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model.
    Kloppenburg GT; Grauls GE; Bruggeman CA; Stassen FR
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):31-4. PubMed ID: 18854336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits.
    Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutics of vein graft intimal hyperplasia: 100 years on.
    Wallitt EJ; Jevon M; Hornick PI
    Ann Thorac Surg; 2007 Jul; 84(1):317-23. PubMed ID: 17588453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vein quality in vascular surgery.
    Stansby G
    Lancet; 1998 Apr; 351(9108):1001-2. PubMed ID: 9546500
    [No Abstract]   [Full Text] [Related]  

  • 11. Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis.
    Sawada Y; Onoda K; Imanaka-Yoshida K; Maruyama J; Yamamoto K; Yoshida T; Shimpo H
    Cardiovasc Res; 2007 Jun; 74(3):366-76. PubMed ID: 17383619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.
    Ohnaka M; Marui A; Yamahara K; Minakata K; Yamazaki K; Kumagai M; Masumoto H; Tanaka S; Ikeda T; Sakata R
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):676-82.e2. PubMed ID: 24507892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical cilostazol inhibits neointimal hyperplasia in a rat interposition vein graft model.
    Malliaris SD; Munabi NCO; Akelina Y; Ascherman JA
    Plast Reconstr Surg; 2014 Dec; 134(6):895e-901e. PubMed ID: 25415112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vessel wall and bone marrow syndecan-4 in neointimal hyperplasia: the plot thickens.
    Caplice NM
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):952-3. PubMed ID: 21508338
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia.
    Nakanishi K; Saito Y; Azuma N; Sasajima T
    J Vasc Surg; 2013 Jan; 57(1):182-93, 193.e1-10. PubMed ID: 23127979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of vein graft failure: a review.
    Davies MG; Hagen PO
    Eur J Vasc Endovasc Surg; 1995 Jan; 9(1):7-18. PubMed ID: 7664016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for TGF-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells.
    Fadini GP; Tjwa M
    Atherosclerosis; 2010 Jul; 211(1):32-5. PubMed ID: 20427045
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice.
    Mayr U; Mayr M; Li C; Wernig F; Dietrich H; Hu Y; Xu Q
    Circ Res; 2002 Feb; 90(2):197-204. PubMed ID: 11834713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for vein grafts.
    Mann MJ
    Curr Cardiol Rep; 2000 Jan; 2(1):29-33. PubMed ID: 10980869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.